Glad to announce that Tricopharming has been selected among the 20 most innovative tech startups of Catalonia Region within the framework of the Startup Capital 2019 call!
Startup Capital boosts early stage technological companies helping to accelerate their product development and road map to market by co-financing business plan implementation.
The call is addressed to high technological Startups located in Catalonia region. The catalan startup ecosystem is very dynamic according to recent regional statistics showing a growing trend in startup number with a total 1.504 in 2019, meaning a 38% more than 3 years ago. In the previous editions of the call, selected StartUp were all standing out for their technological and innovation impact.
Time frame is 18 months, starting in November 2019. The initiative consists in a direct grant of up to 75.000 euros for recently-created technological startups, plus a mentoring program carried out by ACCIO via mentorship specialists and major representatives of the technology, health and biotech industry. The initiative finances measures to implement the business plan and to accelerate access to early stage financing rounds.
Thanks to the project we will be able to conduct on-field beta testing to eventually launch on the market our new business line by the end of 2020.
On the other side, thanks to Startup Capital financing, we will be able to scale up faster the production and commercialization of our product Artennua®, since 2019 available in the two formats capsules and B2B bags.
That’s a very good news for us! It joins the good results achieved in 2019: at the beginning of 2019 we took part to the Barcelona Activa pre-Acceleration Program – being to date incubated in the MediaTic Tech StartUps @22 district hub, we received the Cervera project co-funding by CDTI for our R&D activity and last but not least, the ‘Seal of Excellence’ by the European Commission in the framework of the SME Instrument phase 1 call.
